Guido Rasi

4.8k total citations
92 papers, 3.2k citations indexed

About

Guido Rasi is a scholar working on Immunology, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Guido Rasi has authored 92 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 23 papers in Economics and Econometrics and 14 papers in Molecular Biology. Recurrent topics in Guido Rasi's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical Economics and Policy (14 papers) and Immunotherapy and Immune Responses (13 papers). Guido Rasi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical Economics and Policy (14 papers) and Immunotherapy and Immune Responses (13 papers). Guido Rasi collaborates with scholars based in Italy, Netherlands and United States. Guido Rasi's co-authors include Enrico Garaci, Hans‐Georg Eichler, P Sinibaldi Vallebona, Pasquale Pierimarchi, С. Бонини, Annalucia Serafino, Francesco Bistoni, Luigina Romani, Claudia Montagnoli and Silvia Bozza and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guido Rasi

90 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Rasi Italy 37 717 609 483 409 407 92 3.2k
Peter Marks United States 29 555 0.8× 1.5k 2.5× 313 0.6× 783 1.9× 635 1.6× 103 5.0k
Reva Bhushan United States 16 2.7k 3.8× 507 0.8× 329 0.7× 757 1.9× 274 0.7× 17 4.5k
Jeffrey A. Kant United States 32 475 0.7× 1.5k 2.4× 178 0.4× 848 2.1× 782 1.9× 82 4.5k
James J. Devlin United States 34 607 0.8× 1.6k 2.7× 217 0.4× 177 0.4× 189 0.5× 89 4.6k
John E. Murphy United States 33 389 0.5× 1.1k 1.8× 163 0.3× 269 0.7× 284 0.7× 165 4.8k
David Nolan Australia 41 1.3k 1.7× 804 1.3× 110 0.2× 264 0.6× 675 1.7× 149 7.3k
Michael A. Silverman United States 28 860 1.2× 780 1.3× 79 0.2× 279 0.7× 340 0.8× 80 2.7k
Tao Wei China 26 212 0.3× 2.0k 3.3× 308 0.6× 962 2.4× 280 0.7× 103 6.0k
Harpreet Singh India 33 818 1.1× 1.9k 3.2× 180 0.4× 883 2.2× 282 0.7× 162 5.6k
Runsheng Wang United States 19 269 0.4× 632 1.0× 166 0.3× 497 1.2× 310 0.8× 42 3.9k

Countries citing papers authored by Guido Rasi

Since Specialization
Citations

This map shows the geographic impact of Guido Rasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Rasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Rasi more than expected).

Fields of papers citing papers by Guido Rasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Rasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Rasi. The network helps show where Guido Rasi may publish in the future.

Co-authorship network of co-authors of Guido Rasi

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Rasi. A scholar is included among the top collaborators of Guido Rasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Rasi. Guido Rasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jommi, Claudio, Patrizio Armeni, Francesco Costa, et al.. (2021). Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement). Recenti Progressi in Medicina. 112(11). 749–756. 2 indexed citations
2.
Eichler, Hans‐Georg, Róisín Adams, Peter Arlett, et al.. (2021). Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements. International Journal of Technology Assessment in Health Care. 37(1). e83–e83. 15 indexed citations
3.
Ciani, Oriana, Marc Buyse, Michael Drummond, et al.. (2016). Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward. Value in Health. 20(3). 487–495. 101 indexed citations
4.
Eichler, Hans‐Georg, et al.. (2016). Drug Regulation and Pricing — Can Regulators Influence Affordability?. New England Journal of Medicine. 374(19). 1807–1809. 35 indexed citations
5.
Pani, Luca, S. Pecorelli, Giuseppe Rosano, et al.. (2015). Steps Forward in Regulatory Pathways for Acute and Chronic Heart failure. European Journal of Heart Failure. 17(1). 3–8. 7 indexed citations
6.
Eichler, Hans‐Georg, Brigitte Bloechl‐Daum, Daniel Brasseur, et al.. (2013). The risks of risk aversion in drug regulation. Nature Reviews Drug Discovery. 12(12). 907–916. 68 indexed citations
7.
Serafino, Annalucia, Noemi Moroni, Manuela Zonfrillo, et al.. (2012). Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: Evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(6). 1004–1018. 54 indexed citations
8.
Cerreta, Francesca, Hans‐Georg Eichler, & Guido Rasi. (2012). Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines Strategy. New England Journal of Medicine. 367(21). 1972–1974. 92 indexed citations
9.
Russo, Pierluigi, Francesco Saverio Mennini, P.D. Siviero, & Guido Rasi. (2010). Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Annals of Oncology. 21(10). 2081–2087. 55 indexed citations
10.
Bonini, Matteo, Fulvio Braido, Ilaria Baiardini, et al.. (2009). AQUA©: Allergy Questionnaire for Athletes. Development and Validation. Medicine & Science in Sports & Exercise. 41(5). 1034–1041. 73 indexed citations
11.
Rasi, Guido. (2007). Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma. World Journal of Gastroenterology. 13(37). 4986–4986. 36 indexed citations
12.
Naylor, Paul H., et al.. (2007). Immunopharmacology of Thymosin α1 and Cytokine Synergy. Annals of the New York Academy of Sciences. 1112(1). 235–244. 15 indexed citations
13.
Vallebona, P Sinibaldi, et al.. (2004). Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats. International Journal of Cancer. 110(1). 70–75. 4 indexed citations
14.
Бонини, С., Guido Rasi, Luisa Bracci‐Laudiero, Annabella Procoli, & Luigi Aloe. (2003). Nerve Growth Factor: Neurotrophin or Cytokine?. International Archives of Allergy and Immunology. 131(2). 80–84. 90 indexed citations
15.
Бонини, С., et al.. (2001). The heterogeneity of allergic phenotypes: genetic and environmental interactions. Annals of Allergy Asthma & Immunology. 87(6). 48–51. 11 indexed citations
16.
Rasi, Guido, P Sinibaldi Vallebona, Annalucia Serafino, et al.. (2000). A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells. International Journal of Cancer. 85(4). 540–544. 10 indexed citations
17.
Бонини, С., et al.. (1999). Atopic and Vernal Keratoconjunctivitis: A Model for Studying Atopic Disease. Current Problems in Dermatology. 28. 88–94. 8 indexed citations
18.
Garaci, Enrico, Francesca Pica, Guido Rasi, Anna Teresa Palamara, & Cartesio Favalli. (1997). Combination therapy with BRMs in cancer and infectious diseases. Mechanisms of Ageing and Development. 96(1-3). 103–116. 6 indexed citations
19.
Rasi, Guido, Milton G. Mutchnick, Filomena Colella, et al.. (1996). Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.. Gut. 39(5). 679–683. 46 indexed citations
20.
Melino, Gerry, P Sinibaldi Vallebona, Stefania D’Atri, et al.. (1993). Characterization of three melanoma cell lines (TVM-A12, TVM-A-197, TVM-BO): Sensitivity to lysis and effect of retinoic acid. 6. 105–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Marks Breakdown of academic impact, for papers by Reva Bhushan Breakdown of academic impact, for papers by Jeffrey A. Kant Breakdown of academic impact, for papers by James J. Devlin Breakdown of academic impact, for papers by John E. Murphy Breakdown of academic impact, for papers by David Nolan Breakdown of academic impact, for papers by Michael A. Silverman Breakdown of academic impact, for papers by Tao Wei Breakdown of academic impact, for papers by Harpreet Singh Breakdown of academic impact, for papers by Runsheng Wang
Rankless by CCL
2026